Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Show other versions (1)

PURPOSE: Diabetes is a suspected risk factor for pancreatic cancer, but questions remain about whether it is a risk factor or a result of the disease. This study prospectively examined the association between diabetes and the risk of pancreatic adenocarcinoma in pooled data from the NCI pancreatic...

Full description

Bibliographic Details
Main Authors:	Elena, J, Steplowski, E, Yu, K, Hartge, P, Tobias, G, Brotzman, M, Chanock, S, Stolzenberg-Solomon, R, Arslan, A, Bueno-de-Mesquita, H, Helzlsouer, K, Jacobs, E, LaCroix, A, Petersen, G, Zheng, W, Albanes, D, Allen, N, Amundadottir, L, Bao, Y, Boeing, H, Boutron-Ruault, M, Buring, J, Gaziano, J, Giovannucci, E, Duell, E
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
by: Elena, J, et al.
Published: (2012)

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
by: Wolpin, B, et al.
Published: (2010)

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).
by: Jacobs, E, et al.
Published: (2010)

Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.
by: Wolpin, B, et al.
Published: (2010)

An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population
by: Klein, A, et al.
Published: (2013)

An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.
by: Alison P Klein, et al.
Published: (2013-01-01)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
by: Shui, I, et al.
Published: (2014)

Correction: vitamin d metabolic pathway genes and pancreatic cancer risk.
by: Hannah Arem, et al.
Published: (2015-01-01)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
by: Chen, Y, et al.
Published: (2007)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
by: Travis, R, et al.
Published: (2009)

Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition.
by: Berrington de González, A, et al.
Published: (2006)

Artificial intelligence and improved early detection for pancreatic cancer
by: Jun Zhong, et al.
Published: (2023-07-01)

Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium
by: Ose, J, et al.
Published: (2017)

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
by: Campa, D, et al.
Published: (2013)

Leukocyte telomere length in relation to pancreatic cancer risk: a prospective study.
by: Campa, D, et al.
Published: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
by: Machiela, M, et al.
Published: (2012)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
by: Lindström, S, et al.
Published: (2010)

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
by: Rohrmann, S, et al.
Published: (2012)

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
by: Rohrmann, S, et al.
Published: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Ahn, J, et al.
Published: (2009)

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
by: Rizzato, C, et al.
Published: (2013)

Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
by: Campa, D, et al.
Published: (2017)

A prospective study of physical activity and the risk of pancreatic cancer among women (United States)
by: Schairer Catherine, et al.
Published: (2008-02-01)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Lindström, S, et al.
Published: (2012)

The association of circulating adiponectin levels with pancreatic cancer risk: A study within the prospective EPIC cohort
by: Grote, V, et al.
Published: (2011)

The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.
by: Grote, V, et al.
Published: (2012)

Role of Pancreatic Stellate Cells in Chemoresistance in Pancreatic Cancer
by: Joshua eMcCarroll, et al.
Published: (2014-04-01)

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.
by: Campa, D, et al.
Published: (2017)

Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
by: Grote, V, et al.
Published: (2012)

A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
by: Chuang, S, et al.
Published: (2011)

A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
by: Chuang, S, et al.
Published: (2011)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Setiawan, V, et al.
Published: (2007)

Intercepting Pancreatic Cancer: Our Dream Teamʼs Resolve to Stop Pancreatic Cancer
by: Jacks, Tyler E
Published: (2020)

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
by: Grote, V, et al.
Published: (2011)

Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
by: Grote, V, et al.
Published: (2011)

Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
by: Navarrete-Muñoz, E, et al.
Published: (2016)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Cox, D, et al.
Published: (2006)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
by: Shui, I, et al.
Published: (2014)

Current knowledge on pancreatic cancer
by: Juan eIovanna, et al.
Published: (2012-01-01)

Plasma cotinine levels and pancreatic cancer in the EPIC cohort study
by: Leenders, M, et al.
Published: (2011)